UBS downgraded BEL to Neutral but raised the target price to Rs 340. They see positives factored into the stock, leaving little room for surprises, but remain cautiously optimistic about earnings and growth.
AMFI Reshuffle: Five midcap stocks that may get upgraded to largecap
Nuvama Institutional Equities expects five midcap stocks, including Bosch, Zydus Lifesciences and Lodha Developers, to move into the largecap category in AMFI’s H1 CY27 reclassification.